Dysphotopsia Following Laser Peripheral Iridotomy

Incidence of Visual Symptom Following Laser (Nd:YAG ) Peripheral Iridotomy (LPI) in Relation to Position of LPI

NCT01758237•Credit Valley EyeCare

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Narrow Angle Patients at Risk for Angle Closure Glaucoma

Interventions

Neodymium-doped: Yttrium Aluminum Garnet (Nd:YAG) laser

Nd:YAG Laser Peripheral Iridotomy

Locations

Canada

Locations (1)

Credit Valley EyeCare

Mississauga, Ontario, Canada

Key Dates

Start Date

January 1, 2008

Primary Completion Date

January 1, 2009

Completion Date

January 1, 2009

Last Updated

February 13, 2013

Sponsors

Lead Sponsor

Credit Valley EyeCare

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 13, 2013Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions